New Ebola Strain Poses Vaccine Development Challenge

Health officials are racing to develop a vaccine for the Bundibugyo strain of Ebola, which has a fatality rate of up to 50 percent. Unlike the better-known Zaire strain, there is currently no approved vaccine for this variant. The outbreak has raised urgent questions about the timeline for vaccine research and deployment, with experts emphasizing the need for accelerated clinical trials and international cooperation.